IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q4 2023 Holdings

Filed 2024-02-12 | 10 holdings | $120.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$37.2M7,373,41330.8%
Invivyd Inc(IVVD)COM00534A102$36.4M9,248,25030.2%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$15.7M523,28013.0%
Silence Therapeutics PLC(SLN)ADS82686Q101$6.3M363,8005.2%
Curis Inc(CRIS)COM231269309$5.4M421,9514.5%
Springworks Therapeutics IncCOM85205L107$5.2M142,8004.3%
Bridgebio Pharma Inc(BBIO)COM10806X102$4.9M121,2004.1%
Proqr Thrapeutics N VSHS EURON71542109$3.8M1,910,6003.1%
TG Therapeutics Inc(TGTX)COM88322Q108$3.7M216,6003.1%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$2.1M67,4001.7%